A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors.

Shc is a ubiquitously expressed Src homology 2 (SH2) domain protein that can transform fibroblasts and differentiate PC12 cells in a Ras-dependent fashion. Shc binds a variety of tyrosine-phosphorylated growth factor receptors presumably via its carboxyl-terminal SH2 domain. We cloned a fragment of Shc when screening a bacterial expression library with tyrosine-phosphorylated epidermal growth factor (EGF) receptor. Surprisingly, this fragment encodes the amino terminus of Shc, a region that has no significant similarity to an SH2 domain. When expressed as a glutathione S-transferase fusion protein, this amino-terminal domain binds to autophosphorylated EGF receptor, as well as HER2/neu and TrkA receptors. This fragment acts like an SH2 domain in that it does not bind non-phosphorylated EGF receptor or EGF receptor with all tyrosine phosphorylation sites mutated or deleted. Our data define a novel domain in Shc that has the potential to interact with growth factor receptors and other tyrosine-phosphorylated proteins.

• Publication year

  1994

• Venue

  Journal of Biological Chemistry

• Publication date

  1994-12-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0021-9258(18)31593-xPMID 7798194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc

  1994cited by this paper
• Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor

  1994cited by this paper
• Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav

  1994cited by this paper
• Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma.

  1994cited by this paper
• The SH2 domain protein GRB‐7 is co‐amplified, overexpressed and in a tight complex with HER2 in breast cancer.

  1994cited by this paper
• Tyrosines 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells.

  1994cited by this paper
• Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins.

  1994cited by this paper
• Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses.

  1994cited by this paper
• How receptor tyrosine kinases activate Ras.

  1993cited by this paper
• Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells.

  1993cited by this paper
• Shc products are substrates of erbB-2 kinase.

  1993cited by this paper
• SH2 and SH3 domains.

  1993cited by this paper
• Signalling by receptor tyrosine kinases.

  1993cited by this paper
• The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling.

  1992cited by this paper
• Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases.

  1992cited by this paper
• pGSTag--a versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins.

  1992cited by this paper
• High-efficiency expression/cloning of epidermal growth factor-receptor-binding proteins with Src homology 2 domains.

  1992cited by this paper
• Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases

  1992cited by this paper
• A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

  1992cited by this paper
• Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo.

  1992cited by this paper
• Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases.

  1991cited by this paper
• The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC‐gamma.

  1990cited by this paper
• HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.

  1989cited by this paper
• EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

  1989cited by this paper
• Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing.

  1987cited by this paper

• From Attraction to Adaptation: How Soft Power Reduces Climate Vulnerability

  2026cites this paper
• Flood vulnerability assessment in the flood prone area of Khyber Pakhtunkhwa, Pakistan

  2024cites this paper
• Adaptation to Climate Change in 172 Countries: the Importance of Intelligence

  2023cites this paper
• Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer

  2021cites this paper
• Structure-functional implications of longevity protein p66Shc in health and disease.

  2020cites this paper
• Protein Domain Microarrays as a Platform to Decipher Signaling Pathways and the Histone Code.

  2020cites this paper
• Profiling the phosphotyrosine interactome of receptor tyrosine kinases by affinity enrichment-mass spectrometry

  2019cites this paper
• Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease

  2018cites this paper
• The role of IL‐3 in bone

  2018influential citation
• Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.

  2017cites this paper
• Therapeutic Potentials of Curcumin for Alzheimer Disease

  2016cites this paper
• The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness

  2016cites this paper
• Les récepteurs venus kinase (VKRs) de schistosoma mansoni : étude des voies de signalisation de SmVKR1 et rôle de la protéine adaptatrice SmShb

  2016cites this paper
• Decoding Shc Deviance: Evidence of Novel Roles for the Phosphotyrosine Adaptor ShcD in Epidermal Growth Factor Receptor (EGFR) Signalling and Dynamics

  2016cites this paper
• FOR DOCTORAL DEGREE ( Ph . D . )

  2015cites this paper
• Regulation of Cell Proliferation by Receptor Tyrosine Protein Kinases

  2015cites this paper
• Fate Regulator Numb The Mdm2 Oncoprotein Interacts with the Cell

  2014cites this paper
• Modular peptide binding: from a comparison of natural binders to designed armadillo repeat proteins.

  2014cites this paper
• Interleukin-3, Interleukin-5, and Cancer

  2014cites this paper
• Epidermal growth factors in the kidney and relationship to hypertension.

  2013cites this paper
• Screening interactions between proteins and disordered peptides by a novel computational method

  2013cites this paper
• Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.

  2013cites this paper
• Repulsive axonal pathfinding requires the Ena/VASP family of actin regulatory proteins in vertebrates

  2012cites this paper
• Protein-Peptide Interactions Revolutionize Drug Development

  2012cites this paper
• Teaching an old dogma new tricks: twenty years of Shc adaptor signalling.

  2012cites this paper
• Phosphotyrosine recognition domains: the typical, the atypical and the versatile

  2012influential citation
• Differential Signaling by Adaptor Molecules LRP1 and ShcA Regulates Adipogenesis by the Insulin-like Growth Factor-1 Receptor*

  2011cites this paper
• MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif

  2011cites this paper
• Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells.

  2011cites this paper
• CHAPTER 5 – Mechanism of Action of Hormones That Act at the Cell Surface

  2011cites this paper
• The Role of ShcA Phosphotyrosine Signaling in the Myocardium

  2011cites this paper
• FUNCTIONAL CHARACTERISATION OF THE ADAPTOR PROTEIN SHCD/RALP

  2011cites this paper
• Function analysis of Xenopus NumbL in the context of primary neurogenesis

  2011cites this paper
• The mechanism of signal transduction by the GPI anchored Prod 1 protein

  2010cites this paper
• Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.

  2010cites this paper
• The Tie2 RTK : regulation and downstream signaling.

  2009cites this paper
• Identification of a Novel Negative Regulator of Activin/Nodal Signaling in Mesendodermal Formation of Xenopus Embryos*

  2009cites this paper
• Mechanisms that regulate adaptor binding to β-integrin cytoplasmic tails

  2009cites this paper
• Using peptide array to identify binding motifs and interaction networks for modular domains.

  2009cites this paper
• Structure and requirement of the Spt6 SH2 domain and an in vitro system to test the "torpedo model" of transcription termination

  2009cites this paper
• 14-3-3 and FHA domains mediate phosphoprotein interactions.

  2009cites this paper
• Reduction of Hepatic CEACAM1 Levels: an Early Mechanism of Insulin Resistance Induced by High-Fat Diet

  2008cites this paper
• p66shc negatively regulates IGF-I signal transduction via inhibition of p52shc binding to SHPS-1 leading to impaired Grb2 membrane recruitment

  2008cites this paper
• Rewiring ret : PTB-adaptor regulated signaling and cell biology

  2008cites this paper
• p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.

  2008cites this paper
• Indirect recruitment of the signalling adaptor Shc to the fibroblast growth factor receptor 2 (FGFR2).

  2008cites this paper
• Requirement of Adaptor Protein GULP during Stabilin-2-mediated Cell Corpse Engulfment*

  2008cites this paper
• Functional coupling of the mammalian EGF receptor to the Ras/cAMP pathway in the yeast Saccharomyces cerevisiae

  2008influential citation
• A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation.

  2008cites this paper
• Reelin/Dab1 Signaling in the Developing Cerebral Cortex

  2008cites this paper
• Gene synthesis, cloning, expression, purification and biophysical characterization of the C2 domain of human tensin

  2007cites this paper
• Defining SH2 domain and PTP specificity by screening combinatorial peptide libraries.

  2007cites this paper
• Engineering the Recruitment of Phosphotyrosine Binding Domain-containing Adaptor Proteins Reveals Distinct Roles for RET Receptor-mediated Cell Survival*

  2006cites this paper
• beta1 integrins modulate p66ShcA expression and EGF-induced MAP kinase activation in fetal lung cells.

  2006cites this paper
• The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain‐derived neurotrophic factor

  2006cites this paper
• Tissue-specific expression of Fgfr2b and Fgfr2c isoforms, Fgf10 and Fgf9 in the developing chick mandible.

  2006cites this paper
• Membrane and juxtamembrane targeting by PH and PTB domains.

  2006cites this paper
• Clathrin Adaptor Proteins in Cargo Endocytosis

  2006cites this paper
• Choline kinase: an important target for cancer.

  2006cites this paper
• Structure and physiologic function of the low-density lipoprotein receptor.

  2005cites this paper
• RGS12 Interacts with the SNARE-binding Region of the Cav2.2 Calcium Channel*

  2005cites this paper
• ISOFORM-SPECIFIC ROLES OF THE ADAPTOR PROTEIN

  2005influential citation
• Protein-Protein Recognition in Phosphotyrosine-Mediated Intracellular Signaling

  2005cites this paper
• Structural and evolutionary division of phosphotyrosine binding (PTB) domains.

  2005cites this paper
• Structure of the adaptor protein p14 reveals a profilin-like fold with distinct function.

  2005cites this paper
• Notch 1 interacts with the amyloid precursor protein in a Numb‐independent manner

  2005cites this paper
• The role of interleukin-3 in classical Hodgkin's disease

  2005cites this paper
• Expression of short peptides in vivo to modulate protein interactions

  2005cites this paper
• Protein-protein interactions in GnRH receptor signalling

  2005cites this paper
• Overview of Protein Structural and Functional Folds

  2004cites this paper
• CEACAM1 : a molecular link between fat metabolism and insulin clearance

  2004cites this paper
• PTB or Not to Be: Promiscuous, Tolerant and Bizarro Domains Come of Age

  2004cites this paper
• Islet-brain (IB)/JNK-interacting proteins (JIPs): future targets for the treatment of neurodegenerative diseases?

  2004cites this paper
• The dual-function disabled-1 PTB domain exhibits site independence in binding phosphoinositide and peptide ligands.

  2004cites this paper
• The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis.

  2004cites this paper
• A Novel Transmembrane Protein Recruits Numb to the Plasma Membrane during Asymmetric Cell Division*

  2004cites this paper
• A Unique Autophosphorylation Site on Tie2/Tek Mediates Dok-R Phosphotyrosine Binding Domain Binding and Function

  2003cites this paper
• Selective interaction of megalin with postsynaptic density-95 (PSD-95)-like membrane-associated guanylate kinase (MAGUK) proteins.

  2003cites this paper
• Examining both sides of a Janus PTB domain.

  2003cites this paper
• Signal Transduction Pathways That Regulate Neural Stem Cell Division and Differentiation

  2003cites this paper
• Exploring biochemistry and cellular biology with protein libraries.

  2003cites this paper
• SH2 and PTB Domains in Tyrosine Kinase Signaling

  2003cites this paper
• Roles of FGF receptors in mammalian development and congenital diseases.

  2003cites this paper
• Identification of a mouse orthologue of the CED-6 gene of Caenorhabditis elegans.

  2003cites this paper
• EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).

  2003cites this paper
• Coupling of folding and binding in the PTB domain of the signaling protein Shc.

  2003cites this paper
• Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes.

  2003cites this paper
• Genetic Etiologies of Craniosynostosis

  2003cites this paper
• Hypoxic Induction of the Hypoxia-Inducible Factor Is Mediated via the Adaptor Protein Shc in Endothelial Cells

  2002cites this paper
• Tyrosine Phosphorylation of the β-Amyloid Precursor Protein Cytoplasmic Tail Promotes Interaction with Shc*

  2002cites this paper
• Interaction domains: from simple binding events to complex cellular behavior

  2002cites this paper
• Serine/Threonine Phosphorylation of ShcA

  2002cites this paper
• Role of integrins in cell invasion and migration

  2002cites this paper
• Phosphotyrosine-binding domains in signal transduction

  2002cites this paper
• PTB or not PTB – that is the question

  2002cites this paper
• FRS2 PTB Domain Conformation Regulates Interactions with Divergent Neurotrophic Receptors*

  2002cites this paper
• Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases

  2002cites this paper
• Signalling Pathways Operated by Receptor Protein Tyrosine Kinases

  2002cites this paper
• Evidence for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation and processing of beta-APP.

  2002cites this paper
• Charakterisierung der Regulation der gerichteten Migration und Invasion humaner Pankreaskarzinomzellen durch den neuronalen Wachstumsfaktor GDNF

  2002cites this paper